Theresa Tse
Chairman bij SINO BIOPHARMACEUTICAL LIMITED
Vermogen: 2 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Theresa Tse
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 | |
| Public Company | Financial Conglomerates | 20 | |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
invoX Pharma Ltd.
 invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The private company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd.
3
| Subsidiary | 3 | |
Sino Biopharmaceutical (Beijing) Ltd.
 Sino Biopharmaceutical (Beijing) Ltd. Miscellaneous Commercial ServicesCommercial Services Sino Biopharmaceutical (Beijing) Ltd. is an investment holding company. Its sole asset is its 33.6% interest in Beijing Tide Pharmaceutical Co., Ltd., a pharmaceutical company established in China with limited liability, which develops, manufactures, and market pharmaceutical products. Sino Biopharmaceutical (Beijing) was founded on December 31, 2007 and is headquartered in Hong Kong.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Theresa Tse via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| MEDIVIR AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Karolinska Institutet | College/University | Chairman Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
Karolinska Institutet Holding AB
 Karolinska Institutet Holding AB Investment Trusts/Mutual FundsMiscellaneous Part of Karolinska Institutet Holding AB, Nätverk Karolinska Institutet Science Park AB (KISP) facilitates interaction between academia and industry on Campus Solna. The private company is based in Solna, Sweden. KISP collaborates closely with Karolinska Institutet, Akademiska Hus, and AWL to organize seminars, workshops, and networking events that help researchers, startups, and established companies connect and gain new insights. The CEO of the Swedish company is Karl Johan Ingvar Weigelt. | Investment Trusts/Mutual Funds | Chief Executive Officer General Counsel | |
LTT Bio-Pharma Co., Ltd.
 LTT Bio-Pharma Co., Ltd. BiotechnologyHealth Technology LTT Bio-Pharma Co. Ltd. engages in the research and development of drugs and new technologies. It also provides pharmaceuticals through drug delivery systems technology which delivers a required amount of drugs to the target site at the expected time; drug discovery; and dispensing pharmacy services. The company was founded by Yutaka Mizushima on April 1988 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member Director/Board Member | |
Beijing Tide Pharmaceutical Co., Ltd.
 Beijing Tide Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Tide Pharmaceutical Co., Ltd. engages in research, development, manufacturing and sale of pharmaceutical products. The firm's products include kaifen flurbiprofen axetil injection, kaishi alprostadil injection, kaina beraprost sodium tablet and deyou pronase granules. The company was founded in May 1995 and is headquartered in Beijing, China. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member Director/Board Member | |
| University of Hong Kong | College/University | Undergraduate Degree Undergraduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Chief Executive Officer Director of Finance/CFO | |
| SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member Director/Board Member | |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Other Consumer Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Lund | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd.
 Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sino Biopharmaceutical Ltd., Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd. researches and produces new pharmaceutical products. The private company is based in Beijing, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Hong Kong Institute of Certified Public Accountants
 Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Qingdao Chia Tai Haier Pharmaceutical Co. Ltd.
 Qingdao Chia Tai Haier Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Qingdao Chia Tai Haier Pharmaceutical Co. Ltd. manufactures and sells pharmaceuticals. It is a subsidiary of Chia Tai Wing Fuk Ltd. It is headquartered in Qingdao, China | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Qingdao Hengshengtang Drugstore Co., Ltd.
 Qingdao Hengshengtang Drugstore Co., Ltd. Drugstore ChainsRetail Trade Part of Sino Biopharmaceutical Ltd., Qingdao Hengshengtang Drugstore Co., Ltd. is a private company that retails pharmaceuticals. The company is based in Qingdao, China. | Drugstore Chains | Director/Board Member Director/Board Member | |
Qingdao Haier Medicine Co. Ltd.
 Qingdao Haier Medicine Co. Ltd. Medical DistributorsDistribution Services Part of Sino Biopharmaceutical Ltd., Qingdao Haier Medicine Co. Ltd. is a private company that distributes pharmaceuticals. The company is based in Qingdao, China. | Medical Distributors | Director/Board Member Director/Board Member | |
| PROMIMIC AB | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Jiangsu Nongken Group Co., Ltd.
 Jiangsu Nongken Group Co., Ltd. Agricultural Commodities/MillingProcess Industries Jiangsu Nongken Group Co., Ltd. operates state-owned farms and related assets. The private company is based in Nanjing, China. The Chinese company is a subsidiary ultimately controlled by the Province of Jiangsu. The company was founded in 1952. The CEO is Zhao Hui Hu. | Agricultural Commodities/Milling | Chief Executive Officer Chairman | |
| KCIF Fund Management AB | Director/Board Member Chairman Director/Board Member | ||
| Nanjing Medical University | College/University | Doctorate Degree Doctorate Degree | |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | ||
| Friends of Hong Kong Association Ltd. | Corporate Officer/Principal Chief Executive Officer | ||
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Chairman | |
Yancheng Suhai Pharmaceutical Co., Ltd.
 Yancheng Suhai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Yancheng Suhai Pharmaceutical Co., Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. The private company is based in Dafeng, China. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
 Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. The private company is based in Dafeng, China. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| CT Green Continent Pharmaceutical Technology Co. Ltd. | Director/Board Member Director/Board Member Director/Board Member | ||
| Shanghai Tongyong Pharmaceutical Co., Ltd. | Chairman Director/Board Member | ||
| Xian CP Pharmaceutical Co. Ltd. | Chairman Chief Executive Officer | ||
Chia Tai Pharmaceutical Investment (Beijing) Co., Ltd.
 Chia Tai Pharmaceutical Investment (Beijing) Co., Ltd. Financial ConglomeratesFinance Part of Sino Biopharmaceutical Ltd., Chia Tai Pharmaceutical Investment (Beijing) Co., Ltd. operates as an investment holding Chinese company. The private company is based in Beijing, China. | Financial Conglomerates | Director/Board Member Director/Board Member | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| OSSDSIGN AB | Medical Specialties | Director/Board Member Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
| KD Incentive AB | Director/Board Member Director/Board Member Director/Board Member | ||
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chairman Chief Executive Officer | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Chairman Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| Scibase AB | Director/Board Member Director/Board Member | ||
| JIANGSU PROVINCIAL AGRICULTURAL RECLAMATION AND DEVELOPMENT CO.,LTD. | Agricultural Commodities/Milling | Director/Board Member Chairman | |
| Chia Tai Shaoyang Orthopedic Hospital | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | ||
Svenska Vaccinfabriken Produktion AB
 Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
Softhale NV
 Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Perma Ventures AB
 Perma Ventures AB Investment ManagersFinance Perma Ventures AB provides financial advisory services. The private company is based in Stockholm, Sweden. | Investment Managers | Director/Board Member Director/Board Member | |
| Chia Tai Yeheng Biotech (Shanghai) Co., Ltd. | Director/Board Member Director/Board Member | ||
VOC Diagnostics AB
 VOC Diagnostics AB Medical/Nursing ServicesHealth Services VOC Diagnostics AB is a cancer diagnostics firm focusing on detection of ovarian cancer as a first indication. The company was founded by György Horvath in 2017 and is headquartered in Solna, Sweden. | Medical/Nursing Services | Chairman Chief Executive Officer | |
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Cp Pharmaceutical Qingdao Co. Ltd.
 Cp Pharmaceutical Qingdao Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Cp Pharmaceutical Qingdao Co. Ltd. is a private company that engages in the research and development, production, and sale of osteoporosis medicines and marine pharmaceuticals. Cp Pharmaceutical Qingdao Co. Ltd. is based in Qingdao, China. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
| Guanghua School of Management | College/University | Masters Business Admin Corporate Officer/Principal |
Statistieken
Internationaal
| Zweden | 25 |
| China | 19 |
| Hongkong | 5 |
| Verenigde Staten | 3 |
| Japan | 2 |
Sectoraal
| Health Technology | 17 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 4 |
| Process Industries | 3 |
Operationeel
| Director/Board Member | 285 |
| Corporate Officer/Principal | 107 |
| Chairman | 64 |
| Independent Dir/Board Member | 56 |
| Chief Executive Officer | 37 |
Sterkste connecties
| Insiders | |
|---|---|
| Gunnar Magnus Modee Persson | 51 |
| Ping Tse | 43 |
| Viktor Drvota | 41 |
| Per Gunnar Ernst Aniansson | 31 |
| Hans Lennart Rudolf Wigzell | 30 |
| Zheng Fei Lu | 27 |
| Karl Härfstrand | 23 |
| Anna Lefevre Skjöldebrand | 17 |
| Kwok Tung Li | 17 |
| Bao Wen Zhang | 16 |
| Hsin Tse | 15 |
| Cheung Ling Cheng | 15 |
| Björn Cochlovius | 14 |
| Fredrik Järrsten | 12 |
| John Öhd | 11 |
- Beurs
- Insiders
- Theresa Tse
- Bedrijfsconnecties
